Citizens Maintains Market Outperform on Enovis, Lowers Price Target to $47
Citizens analyst David Turkaly maintains Enovis (NYSE:ENOV) with a Market Outperform and lowers the price target from $55 to $47.
Stocks · News reference
Wells Fargo Maintains Overweight on Enovis, Lowers Price Target to $33
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Freedom Capital Markets Maintains Buy on Enovis, Lowers Price Target to $36
Freedom Capital Markets analyst Keith Hinton maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $41 to $36.
Enovis shares are trading lower. The company announced a binding offer to acquire eCential Robotics for an upfront enterprise value of €155 million.